 |
|
Cancer Incidence Before and After Kidney Transplantation
Claire M. Vajdic, PhD;
Stephen P. McDonald, PhD;
Margaret R. E. McCredie, PhD;
Marina T. van Leeuwen, MPH;
John H. Stewart, MB, ChB;
Matthew Law, PhD;
Jeremy R. Chapman, MD;
Angela C. Webster, PhD;
John M. Kaldor, PhD;
Andrew E. Grulich, PhD
JAMA. 2006;296:2823-2831.
Context Immune suppression after organ transplantation is associated with a markedly increased risk of nonmelanoma skin cancer and a few virus-associated cancers. Although it is generally accepted that other cancers do not occur at increased rates, there have been few long-term population-based cohort studies performed.
Objective To compare the incidence of cancer in patients receiving immune suppression after kidney transplantation with incidence in the same population in 2 periods before receipt of immune suppression: during dialysis and during end-stage kidney disease before renal replacement therapy (RRT).
Design, Setting, and Participants A population-based cohort study of 28 855 patients with end-stage kidney disease who received RRT, with 273 407 person-years of follow-up. Incident cancers (1982-2003) were ascertained by record linkage between the Australia and New Zealand Dialysis and Transplant Registry and the Australian National Cancer Statistics Clearing House.
Main Outcome Measure Standardized incidence ratios (SIRs) of cancer, using age-specific, sex-specific, calendar year–specific, and state/territory–specific population cancer incidence rates.
Results The overall incidence of cancer, excluding nonmelanoma skin cancer and those cancers known to frequently cause end-stage kidney disease, was markedly increased after transplantation (n = 1236; SIR, 3.27; 95% confidence interval [CI], 3.09-3.46). In contrast, cancer incidence was only slightly increased during dialysis (n = 870; SIR, 1.35; 95% CI, 1.27-1.45) and before RRT (n = 689; SIR, 1.16; 95% CI, 1.08-1.25). After transplantation, cancer occurred at significantly increased incidence at 25 sites, and risk exceeded 3-fold at 18 of these sites. Most of these cancers were of known or suspected viral etiology.
Conclusions Kidney transplantation is associated with a marked increase in cancer risk at a wide variety of sites. Because SIRs for most types of cancer were not increased before transplantation, immune suppression may be responsible for the increased risk. These data suggest a broader than previously appreciated role of the interaction between the immune system and common viral infections in the etiology of cancer.
Author Affiliations: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia (Drs Vajdic, Law, Kaldor, and Grulich, and Ms van Leeuwen); Australia and New Zealand Dialysis and Transplant Registry, Queen Elizabeth Hospital, Adelaide, Australia (Drs McDonald, Chapman, and Webster); Disciplines of Medicine and Public Health, University of Adelaide, Adelaide, Australia (Dr McDonald); Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand (Drs McCredie and Stewart); and Centre for Transplant and Renal Research, Millennium Institute, Westmead Hospital, University of Sydney, Sydney, Australia (Drs Chapman and Webster).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Immune Response During Therapy With Cisplatin or Radiation for Human Papillomavirus-Related Head and Neck Cancer
Spanos et al.
Arch Otolaryngol Head Neck Surg 2009;135:1137-1146.
ABSTRACT
| FULL TEXT
Malignancy incidence after renal transplantation in children: a 20-year single centre experience
Koukourgianni et al.
Nephrol Dial Transplant 2009;0:gfp497v1-gfp497.
ABSTRACT
| FULL TEXT
Incidence of Merkel cell carcinoma in renal transplant recipients
Koljonen et al.
Nephrol Dial Transplant 2009;24:3231-3235.
ABSTRACT
| FULL TEXT
The pattern of excess cancer in dialysis and transplantation
Stewart et al.
Nephrol Dial Transplant 2009;24:3225-3231.
ABSTRACT
| FULL TEXT
Immunosuppressive Drugs and Tregs: A Critical Evaluation!
De Serres et al.
CJASN 2009;4:1661-1669.
ABSTRACT
| FULL TEXT
The HSP72 stress response of monocytes from patients on haemodialysis is impaired
Reuter et al.
Nephrol Dial Transplant 2009;24:2838-2846.
ABSTRACT
| FULL TEXT
Risk of Human Papillomavirus-Associated Cancers Among Persons With AIDS
Chaturvedi et al.
JNCI J Natl Cancer Inst 2009;101:1120-1130.
ABSTRACT
| FULL TEXT
Does HIV/AIDS Have a Biological Impact on the Risk of Human Papillomavirus-Related Cancers?
Strickler
JNCI J Natl Cancer Inst 2009;101:1103-1105.
FULL TEXT
Elevated Cutaneous Smad Activation Associates with Enhanced Skin Tumor Susceptibility in Organ Transplant Recipients
Harradine et al.
Clin. Cancer Res. 2009;15:5101-5107.
ABSTRACT
| FULL TEXT
Cutaneous Melanoma Is Related to Immune Suppression in Kidney Transplant Recipients
Vajdic et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:2297-2303.
ABSTRACT
| FULL TEXT
Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation
van Leeuwen et al.
Blood 2009;114:630-637.
ABSTRACT
| FULL TEXT
Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy, and Survival at a Transplantation Center
Knight et al.
JCO 2009;27:3354-3362.
ABSTRACT
| FULL TEXT
Reported cancer screening practices of nephrologists: results from a national survey
Wong et al.
Nephrol Dial Transplant 2009;24:2136-2143.
ABSTRACT
| FULL TEXT
High-grade urothelial carcinoma in a kidney transplant recipient with BK virus infection
Hill et al.
NDT Plus 2009;2:246-249.
ABSTRACT
| FULL TEXT
Association of CKD and Cancer Risk in Older People
Wong et al.
J. Am. Soc. Nephrol. 2009;20:1341-1350.
ABSTRACT
| FULL TEXT
Cancer risks in Crohn disease patients
Hemminki et al.
Ann Oncol 2009;20:574-580.
ABSTRACT
| FULL TEXT
The uptake of cervical cancer screening by renal transplant recipients
Courtney et al.
Nephrol Dial Transplant 2009;24:647-652.
ABSTRACT
| FULL TEXT
Immunosuppression and Other Risk Factors for Lip Cancer after Kidney Transplantation
van Leeuwen et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:561-569.
ABSTRACT
| FULL TEXT
Kidney transplantation--the long term view
O'Callaghan
QJM 2008;101:985-986.
FULL TEXT
Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992-2003
Patel et al.
ANN INTERN MED 2008;148:728-736.
ABSTRACT
| FULL TEXT
Cancer risk in hospitalized rheumatoid arthritis patients
Hemminki et al.
Rheumatology (Oxford) 2008;47:698-701.
ABSTRACT
| FULL TEXT
Cancer Screening in Renal Transplant Recipients: What Is the Evidence?
Wong et al.
CJASN 2008;3:S87-S100.
ABSTRACT
| FULL TEXT
Effect of Melanoma on Immune Function in the Regional Lymph Node Basin
Negin et al.
Clin. Cancer Res. 2008;14:654-659.
ABSTRACT
| FULL TEXT
Renal Transplantation
Bennett et al.
CJASN 2008;3:7-9.
FULL TEXT
Increased Incidence of Squamous Cell Carcinoma of Eye After Kidney Transplantation
Vajdic et al.
JNCI J Natl Cancer Inst 2007;99:1340-1342.
ABSTRACT
| FULL TEXT
Comparison of Stage at Diagnosis of Cancer in Patients Who Are on Dialysis versus the General Population
Taneja et al.
CJASN 2007;2:1008-1013.
ABSTRACT
| FULL TEXT
Risk of Germ Cell Tumors among Men with HIV/Acquired Immunodeficiency Syndrome
Goedert et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1266-1269.
ABSTRACT
| FULL TEXT
|
